Rocket Pharmaceuticals, Inc. is a cutting-edge biotechnology firm headquartered in Cranbury, New Jersey, specializing in pioneering gene therapies for rare and life-threatening pediatric conditions. Utilizing its proprietary platform technologies, the company is dedicated to addressing critical unmet medical needs through the development of transformative treatments. With a solid pipeline designed to enhance patient outcomes, Rocket is strategically positioned to spearhead innovation in the management of severe genetic disorders, reaffirming its commitment to advancing the landscape of gene therapy. Show more

Location: 9 CEDARBROOK DRIVE, CRANBURY, NJ, UNITED STATES, 08512, Cranbury, NJ, 08512, USA | Website: https://www.rocketpharma.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

324.7M

52 Wk Range

$2.19 - $11.11

Previous Close

$3.00

Open

$3.10

Volume

2,183,331

Day Range

$3.07 - $3.22

Enterprise Value

161.6M

Cash

75.95M

Avg Qtr Burn

-50.43M

Insider Ownership

3.69%

Institutional Own.

91.06%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
KRESLADI (Marnetegragene autotemcel) /RP-L201 Details Immunodeficiency, Leukocyte Adhesion Deficiency	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RP-L102 Details Rare diseases, Blood disorder, Fanconi Anemia	BLA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RP-L301 Details Pyruvate Kinase Deficiency	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RP-A501 Details Immunodeficiency, Danon Disease	Phase 2 Re-initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RP-A601 Details Arrhythmogenic cardiomyopathy	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RP-A701 Details BAG3-associated Dilated Cardiomyopathy	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RP-L401 Details Infantile Malignant Osteopetrosis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.